Annual Accounts Payable
$2.23 M
+$677.20 K+43.69%
December 31, 2023
Summary
- As of March 4, 2025, OPRX annual accounts payable is $2.23 million, with the most recent change of +$677.20 thousand (+43.69%) on December 31, 2023.
- During the last 3 years, OPRX annual accounts payable has risen by +$1.61 million (+260.27%).
- OPRX annual accounts payable is now at all-time high.
Performance
OPRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.75 M
-$226.00 K-7.58%
September 30, 2024
Summary
- As of March 4, 2025, OPRX quarterly accounts payable is $2.75 million, with the most recent change of -$226.00 thousand (-7.58%) on September 30, 2024.
- Over the past year, OPRX quarterly accounts payable has stayed the same.
- OPRX quarterly accounts payable is now -7.58% below its all-time high of $2.98 million, reached on June 30, 2024.
Performance
OPRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
OPRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.7% | 0.0% |
| 3 y3 years | +260.3% | +353.9% |
| 5 y5 years | +441.9% | +458.6% |
OPRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +267.0% | -7.6% | +358.5% |
| 5 y | 5-year | at high | +351.8% | -7.6% | +473.1% |
| alltime | all time | at high | +6608.4% | -7.6% | >+9999.0% |
OptimizeRx Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.75 M(-7.6%) |
| Jun 2024 | - | $2.98 M(+79.0%) |
| Mar 2024 | - | $1.67 M(-25.2%) |
| Dec 2023 | $2.23 M(+43.7%) | $2.23 M(+222.2%) |
| Sep 2023 | - | $691.20 K(-15.5%) |
| Jun 2023 | - | $817.80 K(-36.6%) |
| Mar 2023 | - | $1.29 M(-16.8%) |
| Dec 2022 | $1.55 M(+155.4%) | $1.55 M(+54.9%) |
| Sep 2022 | - | $1.00 M(-22.8%) |
| Jun 2022 | - | $1.30 M(+115.7%) |
| Mar 2022 | - | $600.70 K(-1.0%) |
| Dec 2021 | $606.80 K(-1.8%) | $606.80 K(-21.4%) |
| Sep 2021 | - | $771.60 K(-4.2%) |
| Jun 2021 | - | $805.50 K(+61.3%) |
| Mar 2021 | - | $499.30 K(-19.2%) |
| Dec 2020 | $618.20 K(+25.4%) | $618.20 K(+28.7%) |
| Sep 2020 | - | $480.50 K(-3.3%) |
| Jun 2020 | - | $496.70 K(-9.4%) |
| Mar 2020 | - | $548.10 K(+11.2%) |
| Dec 2019 | $493.00 K(+20.0%) | $493.00 K(-55.0%) |
| Sep 2019 | - | $1.10 M(+20.1%) |
| Jun 2019 | - | $911.80 K(+55.9%) |
| Mar 2019 | - | $584.80 K(+42.3%) |
| Dec 2018 | $411.00 K(-10.1%) | $411.00 K(+148.3%) |
| Sep 2018 | - | $165.50 K(-6.4%) |
| Jun 2018 | - | $176.90 K(+32.1%) |
| Mar 2018 | - | $133.90 K(-70.7%) |
| Dec 2017 | $457.30 K(+23.9%) | $457.30 K(-36.6%) |
| Sep 2017 | - | $720.80 K(-20.3%) |
| Jun 2017 | - | $904.00 K(+70.4%) |
| Mar 2017 | - | $530.40 K(+43.7%) |
| Dec 2016 | $369.20 K | $369.20 K(+92.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $191.40 K(-1.7%) |
| Jun 2016 | - | $194.70 K(-0.2%) |
| Mar 2016 | - | $195.10 K(-75.1%) |
| Dec 2015 | $782.20 K(+1.5%) | $782.20 K(+5.0%) |
| Sep 2015 | - | $744.90 K(+0.4%) |
| Jun 2015 | - | $742.20 K(+1.2%) |
| Mar 2015 | - | $733.10 K(-4.8%) |
| Dec 2014 | $770.40 K(+1.5%) | $770.40 K(+16.5%) |
| Sep 2014 | - | $661.30 K(-29.1%) |
| Jun 2014 | - | $932.60 K(+16.5%) |
| Mar 2014 | - | $800.20 K(+5.5%) |
| Dec 2013 | $758.70 K(+21.5%) | $758.70 K(+1.9%) |
| Sep 2013 | - | $744.50 K(+27.9%) |
| Jun 2013 | - | $582.10 K(-7.1%) |
| Mar 2013 | - | $626.70 K(+0.3%) |
| Dec 2012 | $624.70 K(-31.1%) | $624.70 K(+8.0%) |
| Sep 2012 | - | $578.50 K(-22.6%) |
| Jun 2012 | - | $747.50 K(+0.2%) |
| Mar 2012 | - | $746.10 K(-17.7%) |
| Dec 2011 | $906.70 K(+49.0%) | $906.70 K(+51.3%) |
| Sep 2011 | - | $599.10 K(-1.4%) |
| Jun 2011 | - | $607.50 K(-9.2%) |
| Mar 2011 | - | $669.10 K(+10.0%) |
| Dec 2010 | $608.40 K(+1732.5%) | $608.40 K(-3.0%) |
| Sep 2010 | - | $627.40 K(+1.1%) |
| Jun 2010 | - | $620.80 K(+4398.6%) |
| Mar 2010 | - | $13.80 K(-58.4%) |
| Dec 2009 | $33.20 K(-80.7%) | $33.20 K(+181.4%) |
| Sep 2009 | - | $11.80 K(-57.4%) |
| Jun 2009 | - | $27.70 K(-84.8%) |
| Mar 2009 | - | $182.80 K(+6.3%) |
| Dec 2008 | $171.90 K(+297.9%) | $171.90 K |
| Dec 2007 | $43.20 K | - |
FAQ
- What is OptimizeRx annual accounts payable?
- What is the all time high annual accounts payable for OptimizeRx?
- What is OptimizeRx annual accounts payable year-on-year change?
- What is OptimizeRx quarterly accounts payable?
- What is the all time high quarterly accounts payable for OptimizeRx?
- What is OptimizeRx quarterly accounts payable year-on-year change?
What is OptimizeRx annual accounts payable?
The current annual accounts payable of OPRX is $2.23 M
What is the all time high annual accounts payable for OptimizeRx?
OptimizeRx all-time high annual accounts payable is $2.23 M
What is OptimizeRx annual accounts payable year-on-year change?
Over the past year, OPRX annual accounts payable has changed by +$677.20 K (+43.69%)
What is OptimizeRx quarterly accounts payable?
The current quarterly accounts payable of OPRX is $2.75 M
What is the all time high quarterly accounts payable for OptimizeRx?
OptimizeRx all-time high quarterly accounts payable is $2.98 M
What is OptimizeRx quarterly accounts payable year-on-year change?
Over the past year, OPRX quarterly accounts payable has changed by $0.00 (0.00%)